Scribe Therapeutics, Inc. (SCTX)
Nasdaq: SCTX · CIK 0001853921 · United States
Every official Scribe Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SCTX filings
Scribe Therapeutics, Inc. documents
- Scribe Therapeutics, Inc. 10-K 2026SCTX 10-K 2026: annual report for fiscal 2026
- Scribe Therapeutics, Inc. 10-K 2025SCTX 10-K 2025: annual report for fiscal 2025
- Scribe Therapeutics, Inc. 10-K 2024SCTX 10-K 2024: annual report for fiscal 2024
- Scribe Therapeutics, Inc. 10-K 2023SCTX 10-K 2023: annual report for fiscal 2023
- Scribe Therapeutics, Inc. 10-K 2022SCTX 10-K 2022: annual report for fiscal 2022
- Scribe Therapeutics, Inc. 10-Q 2026SCTX 10-Q 2026: quarterly report for fiscal 2026
- Scribe Therapeutics, Inc. 10-Q 2025SCTX 10-Q 2025: quarterly report for fiscal 2025
- Scribe Therapeutics, Inc. 10-Q 2024SCTX 10-Q 2024: quarterly report for fiscal 2024
- Scribe Therapeutics, Inc. 10-Q 2023SCTX 10-Q 2023: quarterly report for fiscal 2023
- Scribe Therapeutics, Inc. 10-Q 2022SCTX 10-Q 2022: quarterly report for fiscal 2022
- Scribe Therapeutics, Inc. 8-K 2026SCTX 8-K 2026: current report for fiscal 2026
- Scribe Therapeutics, Inc. 8-K 2025SCTX 8-K 2025: current report for fiscal 2025
- Scribe Therapeutics, Inc. 8-K 2024SCTX 8-K 2024: current report for fiscal 2024
- Scribe Therapeutics, Inc. 8-K 2023SCTX 8-K 2023: current report for fiscal 2023
- Scribe Therapeutics, Inc. 8-K 2022SCTX 8-K 2022: current report for fiscal 2022
- Scribe Therapeutics, Inc. DEF 14A 2026SCTX DEF 14A 2026: proxy statement for fiscal 2026
- Scribe Therapeutics, Inc. DEF 14A 2025SCTX DEF 14A 2025: proxy statement for fiscal 2025
- Scribe Therapeutics, Inc. DEF 14A 2024SCTX DEF 14A 2024: proxy statement for fiscal 2024
- Scribe Therapeutics, Inc. DEF 14A 2023SCTX DEF 14A 2023: proxy statement for fiscal 2023
- Scribe Therapeutics, Inc. DEF 14A 2022SCTX DEF 14A 2022: proxy statement for fiscal 2022
- Scribe Therapeutics, Inc. Form 4 2026SCTX Form 4 2026: insider trading filing for fiscal 2026
- Scribe Therapeutics, Inc. Form 4 2025SCTX Form 4 2025: insider trading filing for fiscal 2025
- Scribe Therapeutics, Inc. Form 4 2024SCTX Form 4 2024: insider trading filing for fiscal 2024
- Scribe Therapeutics, Inc. Form 4 2023SCTX Form 4 2023: insider trading filing for fiscal 2023
- Scribe Therapeutics, Inc. Form 4 2022SCTX Form 4 2022: insider trading filing for fiscal 2022
- Scribe Therapeutics, Inc. S-1 2026SCTX S-1 2026: registration statement for fiscal 2026
- Scribe Therapeutics, Inc. S-1 2025SCTX S-1 2025: registration statement for fiscal 2025
- Scribe Therapeutics, Inc. S-1 2024SCTX S-1 2024: registration statement for fiscal 2024
- Scribe Therapeutics, Inc. S-1 2023SCTX S-1 2023: registration statement for fiscal 2023
- Scribe Therapeutics, Inc. S-1 2022SCTX S-1 2022: registration statement for fiscal 2022
- Scribe Therapeutics, Inc. 13F 2026SCTX 13F 2026: institutional holdings for fiscal 2026
- Scribe Therapeutics, Inc. 13F 2025SCTX 13F 2025: institutional holdings for fiscal 2025
- Scribe Therapeutics, Inc. 13F 2024SCTX 13F 2024: institutional holdings for fiscal 2024
- Scribe Therapeutics, Inc. 13F 2023SCTX 13F 2023: institutional holdings for fiscal 2023
- Scribe Therapeutics, Inc. 13F 2022SCTX 13F 2022: institutional holdings for fiscal 2022
More companies